Leap Therapeutics (LPTX) Stock Chart & Stock Price History → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free LPTX Stock Alerts $2.25 -0.04 (-1.75%) (As of 06/11/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Leap Therapeutics Stock Price Performance5 Day Performance+0.89%1 Month Performance-18.35%3 Month Performance-8.47%6 Month Performance-14.66%Year-To-Date Performance-45.24%1 Year Performance-63.09% Receive LPTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. LPTX Stock Chart for Tuesday, June, 11, 2024 LPTX Chart by TradingView Leap Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/10/2024$2.24$2.29+2.23%$2.33$2.19152,004 shs$58.62 million06/07/2024$2.25$2.24-0.44%$2.30$2.2054,077 shs$57.34 million06/06/2024$2.35$2.25-4.26%$2.40$2.2391,385 shs$57.60 million06/05/2024$2.35$2.35+0.21%$2.39$2.2988,336 shs$60.16 million06/04/2024$2.48$2.35-5.44%$2.55$2.33114,889 shs$60.03 million06/03/2024$2.43$2.48+2.06%$2.63$2.38297,243 shs$63.49 million Get the Latest News and Ratings for LPTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/31/2024$2.36$2.43+2.97%$2.46$2.31153,836 shs$62.21 million05/30/2024$2.16$2.36+9.26%$2.37$2.20150,988 shs$60.42 million05/29/2024$2.28$2.16-5.26%$2.20$2.15271,753 shs$55.30 million05/28/2024$2.38$2.28-4.20%$2.47$2.23159,465 shs$58.37 million05/27/2024$2.38$2.38$2.53$2.34180,600 shs$60.93 million05/24/2024$2.47$2.38-3.64%$2.53$2.34180,662 shs$60.93 million05/23/2024$2.50$2.47-1.00%$2.50$2.31225,026 shs$63.23 million05/22/2024$2.51$2.50-0.60%$2.59$2.4997,588 shs$63.87 million05/21/2024$2.57$2.51-2.33%$2.70$2.49326,963 shs$64.26 million05/20/2024$2.63$2.57-2.28%$2.72$2.50116,841 shs$65.79 million05/17/2024$2.74$2.63-4.01%$2.77$2.57375,786 shs$67.33 million05/16/2024$2.80$2.74-2.14%$2.80$2.71133,435 shs$70.14 million05/15/2024$2.75$2.80+1.82%$2.92$2.74300,087 shs$71.68 million05/14/2024$2.83$2.75-2.83%$3.00$2.72247,938 shs$70.40 million05/13/2024$2.78$2.83+1.80%$2.99$2.71205,843 shs$72.45 million05/10/2024$2.91$2.78-4.47%$2.98$2.73125,403 shs$71.17 million05/09/2024$2.99$2.91-2.68%$3.01$2.85146,976 shs$74.50 million05/08/2024$3.07$2.99-2.61%$3.12$2.91161,593 shs$76.54 million05/07/2024$3.22$3.07-4.66%$3.29$3.05206,969 shs$78.59 million05/06/2024$3.19$3.22+0.94%$3.26$3.06238,381 shs$82.43 million05/03/2024$3.17$3.19+0.63%$3.28$3.01334,593 shs$81.66 million05/02/2024$3.27$3.17-3.06%$3.31$3.05137,305 shs$81.15 million05/01/2024$3.10$3.27+5.48%$3.29$3.12151,393 shs$83.71 million04/30/2024$3.07$3.10+0.98%$3.27$3.02105,872 shs$79.36 million04/29/2024$3.25$3.07-5.54%$3.40$3.03130,337 shs$78.59 million04/26/2024$3.17$3.25+2.52%$3.39$2.99403,126 shs$83.20 million04/25/2024$3.29$3.17-3.65%$3.29$3.12212,832 shs$81.15 million04/24/2024$3.20$3.29+2.81%$3.30$3.10200,195 shs$84.22 million04/23/2024$3.21$3.20-0.31%$3.33$3.1089,131 shs$81.92 million04/22/2024$2.80$3.21+14.64%$3.26$2.85328,679 shs$82.18 million04/19/2024$2.96$2.80-5.41%$3.04$2.77211,020 shs$71.68 million04/18/2024$3.00$2.96-1.33%$3.03$2.89101,757 shs$75.78 million04/17/2024$2.98$3.00+0.67%$3.14$2.92146,417 shs$76.80 million04/16/2024$3.00$2.98-0.67%$3.20$2.95151,106 shs$76.29 millionThe Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it.04/15/2024$3.24$3.00-7.41%$3.49$2.75521,737 shs$76.80 million04/12/2024$3.12$3.24+4.01%$3.50$3.07565,216 shs$82.94 million04/11/2024$3.04$3.12+2.47%$4.39$3.035.67 million shs$79.74 million04/10/2024$3.41$3.04-10.85%$3.38$2.91435,581 shs$87.30 million04/09/2024$2.58$3.41+32.17%$3.59$2.591.35 million shs$87.30 million04/08/2024$2.54$2.58+1.57%$2.64$2.5368,225 shs$66.05 million04/05/2024$2.51$2.54+1.20%$2.57$2.4567,326 shs$65.02 million04/04/2024$2.53$2.51-0.79%$2.65$2.4293,873 shs$64.26 million04/03/2024$2.63$2.53-3.80%$2.60$2.42127,003 shs$64.77 million04/02/2024$2.75$2.63-4.36%$2.75$2.5883,945 shs$67.33 million04/01/2024$2.66$2.75+3.38%$2.75$2.55153,631 shs$70.40 million03/29/2024$2.66$2.66$2.98$2.65192,513 shs$68.10 million03/28/2024$2.78$2.66-4.32%$2.98$2.65192,342 shs$68.10 million03/27/2024$2.48$2.78+12.10%$2.81$2.44191,744 shs$71.17 million03/26/2024$2.40$2.48+3.33%$2.51$2.41101,108 shs$63.49 million03/25/2024$2.52$2.40-4.76%$2.52$2.32276,898 shs$61.44 million03/22/2024$2.55$2.52-1.18%$2.63$2.46107,881 shs$64.51 million03/21/2024$2.55$2.55$2.75$2.47289,272 shs$65.28 million03/20/2024$2.20$2.55+15.91%$2.63$2.21157,229 shs$65.20 million03/19/2024$2.14$2.20+2.80%$2.44$2.17317,462 shs$56.25 million03/18/2024$2.21$2.14-3.17%$2.24$2.13145,440 shs$54.72 million03/15/2024$2.20$2.21+0.45%$2.33$2.17149,477 shs$56.51 million03/14/2024$2.29$2.20-3.93%$2.34$2.14129,241 shs$56.25 million03/13/2024$2.50$2.29-8.40%$2.59$2.19255,922 shs$58.56 million03/12/2024$2.48$2.50+0.81%$2.54$2.4388,843 shs$63.93 million03/11/2024$2.50$2.48-0.80%$2.64$2.42215,702 shs$63.41 million Related Companies: ProPhase Labs Stock Price Chart Tonix Pharmaceuticals Stock Price Chart Eliem Therapeutics Stock Price Chart Akebia Therapeutics Stock Price Chart Rani Therapeutics Stock Price Chart Adlai Nortye Stock Price Chart Design Therapeutics Stock Price Chart Acrivon Therapeutics Stock Price Chart XBiotech Stock Price Chart 2seventy bio Stock Price Chart Receive LPTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Leap Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LPTX) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leap Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Leap Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.